You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

COARTEM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Coartem patents expire, and what generic alternatives are available?

Coartem is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in COARTEM is artemether; lumefantrine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the artemether; lumefantrine profile page.

Drug patent expirations by year for COARTEM
Drug Prices for COARTEM

See drug prices for COARTEM

Recent Clinical Trials for COARTEM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Novartis PharmaceuticalsPhase 3
MMV, EDCTP, WANECAMPhase 3
Duke UniversityPhase 4

See all COARTEM clinical trials

Pharmacology for COARTEM
Drug ClassAntimalarial

US Patents and Regulatory Information for COARTEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis COARTEM artemether; lumefantrine TABLET;ORAL 022268-001 Apr 7, 2009 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for COARTEM

See the table below for patents covering COARTEM around the world.

Country Patent Number Title Estimated Expiration
Luxembourg 90844 ⤷  Try a Trial
Spain 2084168 ⤷  Try a Trial
Ireland 911989 ⤷  Try a Trial
Germany 10199038 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9202217 ⤷  Try a Trial
China 1065993 ⤷  Try a Trial
Hungary 9201528 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for COARTEM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0500823 SPC/GB00/013 United Kingdom ⤷  Try a Trial PRODUCT NAME: ARTEMETHER AND LUMEFANTRIN; REGISTERED: CH (IKS) 54594 01 19990122; UK PL 00101/0566 19991130
0500823 C300048 Netherlands ⤷  Try a Trial PRODUCT NAME: ARTEMETHERUM EN LUMEFANTRINUM, DESGEWENST IN DE VORM VAN EEN FA RMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ARTEMETHERUM EN LUMEFANTRINUM; NATL. REGISTRATION NO/DATE: RVG 25773 20010123; FIRST REGISTRATION: CH 54594 19990122
0500823 2001C/043 Belgium ⤷  Try a Trial PRODUCT NAME: ARTEMETHER, LUMEFANTRINE; NAT. REGISTRATION NO/DATE: 206 IS 300 F 3 20010514; FIRST REGISTRATION: CH 54594 19990122
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.